Table 3.
Prognostic factors for local failure (LF)
Factor | No. of patients | 5-year LF (%) | p |
---|---|---|---|
Age at diagnosis | |||
<4 years | 123 | 9.8 | 0.92 |
≥4 years | 123 | 9.5 | |
Site of primary tumor | |||
Abdominal | 232 | 9.7 | 0.77 |
Non-abdominal | 14 | 12.5 | |
MYCN | |||
Non-amplified | 131 | 8.2 | 0.09 |
Amplified | 96 | 14.0 | |
LDH | |||
<1500 | 113 | 6.7 | 0.06 |
≥1500 | 65 | 14.4 | |
Ferritin | |||
<142 | 36 | 6.0 | 0.32 |
≥142 | 88 | 11.9 | |
Shimada histopathology | |||
Favorable | 11 | 0.0 | 0.27 |
Unfavorable | 173 | 12.6 | |
Skeletal metastases | |||
Present | 195 | 7.0 | 0.003 |
Absent | 51 | 20.1 | |
No. of surgeries to achieve GTR | |||
1 | 212 | 8.3 | 0.01 |
>1 | 29 | 22.4 | |
Time from chemotherapy to RT | |||
<7.8 months | 121 | 11.2 | 0.60 |
≥7.8 months | 125 | 8.5 | |
Response to chemotherapy | |||
CR/VGPR | 135 | 11.5 | 0.29 |
PR/MR/PD | 111 | 7.0 | |
Stem cell transplant | |||
Yes | 75 | 6.7 | 0.29 |
No | 171 | 11.5 |
Abbreviations: LF = local failure; GTR = gross total resection; RT = radiation therapy; CR/VGPR = complete remission/very good partial remission; PR/MR/PD = partial remission/mixed response/progressive disease